Kewaunee Scientific Corporation KEQU Finance Lease Liability Payments Due Year Four

Finance Lease Liability Payments Due Year Four at other companies

Bio-Rad LaboratoriesBIO

——

West Pharmaceutical ServicesWST

——

Other financials

Income statement

See full

Revenue$71.4M-7.5%

Gross profit$21.2M-11.6%

Operating income$5.2M-38.6%

Net income$3.4M-30.1%

EPS (diluted)$1.13-30.7%

Balance sheet

See full

Cash & equivalents$10.0M-42.0%

Total debt$25.3M+6.6%

Total equity$74.7M+15.9%

Total assets$178.3M-8.4%

Cash flow

See full

Operating cash flow$5.5M-42.0%

CapEx$928.0K+79.8%

Free cash flow$4.5M-49.0%

Valuation

See full

Market cap$101.96M-34.8%

Enterprise value$117.3M-28.0%

P/E10.6×-3.1×

P/S0.4×-0.3×

Profitability

See full

Gross margin28.5%-0.1pp

Operating margin5.9%-1.5pp

Net margin3.4%-1.3pp

FCF margin5.2%—

Returns & leverage

See full

Return on equity13.8%-5.3pp

Debt / equity0.3×0.0×

Current ratio2.2×0.0×

Where this comes from

Reported directly by Kewaunee Scientific Corporation in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour.

The official record: Kewaunee Scientific Corporation’s 10-Q, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kewaunee Scientific Corporation's finance lease liability payments due year four.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kewaunee Scientific Corporation's finance lease liability payments due year four?: Kewaunee Scientific Corporation (KEQU) reported finance lease liability payments due year four of $94K in Q4 2025.
How has Kewaunee Scientific Corporation's finance lease liability payments due year four changed year-over-year?: Kewaunee Scientific Corporation's finance lease liability payments due year four increased by 135.0% year-over-year, from $40K to $94K.